Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 4, 1996, Pages 358-362

  Wallace, Mark R ^a   Moss, Ronald B ^i,k   Beecham III, H James ^a   Grace, Christopher J ^b   Hersh, Evan M ^c   Peterson, Eskild ^c   Murphy, Robert ^d   Shepp, David H ^e   Siegal, Frederick P ^f   Turner, John L ^g   Safrin, Sharon ^h   Carlo, Dennis J ⁱ   Levine, Alexandra M ^j  

^a Space and Naval Warfare Systems Center Pacific   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^f LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^g GRADUATE HOSPITAL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Immune Response Corporation   (United States)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^k Orchestra Therapeutics Inc   (United States)

more..

Author keywords

CD4 percent; Early HIV clinical events; Surrogate markers

Indexed keywords

BIOCHEMICAL MARKER; CD4 ANTIGEN; FREUND ADJUVANT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SEROCONVERSION; VIRUS CELL INTERACTION; VIRUS INACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 9544226548     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199608010-00005     Document Type: Article

References (19)

1. Kessler DA. Issues in approving drugs for AIDS treatment. Regulatory Affairs 1994;6:189-200.
2. Moss RB, Ferre F, Trauger R, Jensen F, Daigle A, Richieri SP, Carlo DJ. Inactivated HIV-1 immunogen: impact on markers of disease progression. J Acquir Immune Defic Syndr 1994;7:S21-S27.
3. + lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus infection: a review. J Infect Dis 1992; 165:352-63.
4. + lymphocytes are an incomplete surrogate marker for clinical progression in persons with aymptomttic HIV infection taking zidovudine. Ann Intern Med 1993;118:674-80.
5. Schechter M, Harrison LE, Halsey NA, Trade G, Santino M, Moulton LH, Quinn TC. Co-infection with human T-cell lymphotropic virus type I and HIV in Brazil. JAMA 1994; 271:353-7.
6. Taylor JMG, Fahey JL, Detels R, Giorgi JV. CD4 percentage, CD4 number and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr 1989;2:114-24.
7. Greenspan D, Schiodt M, Greenspan JS, Pindborg J. AIDS and the Mouth 1992; Chicago, Illinois: Mosby YearBook.
8. Trauger RJ, Ferre F, Daigle AE, et al. Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen in IFA on HIV-1 immunity, viral DNA, and CD4 percent. J Infect Dis 1994;169:1256-64.
9. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR December 1992; 41.
10. Burcham J, Marmor M, Dubin N, et al. CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS 1991;5:365-72.
11. Margolick JB, Munoz A, Donnenberg AD, et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nature Medicine 1995;1:674-80.
12. Statistical Analysis System, Version 6, SAS Institute Inc., Cary, NC.
13. Gelman R, Eudey L. Biostatistical considerations for quality assessment of immunologic measurements used in clinical and longitudinal studies. Clin Immunol Immunopathol 1989; 52:28-37.
14. Koepke JA, Smith-Jones M. Lymphocyte counting in HIV-positive individuals. Sysmex Journal International 1992;2: 71-4.
15. Embretson J, Zupanic M, Ribas JI, et al. Massive covert infection of helpter T cells: lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993; 362:359-62.
16. Lifson AR, Hilton JF, Westernhouse JL, et al. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among heterosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994;8:73-9.
17. Greenspan D, Greenspan JS, Hearst HG, et al. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis 1987;155:475-81.
18. + cell counts greater than 400 per cubic millimeters N Engl J Med 1993;329:297-303.
19. Henrard DR, Phillips JF, Muenz LR, et al. Natural history of HIV-1 cell-free viremia. JAMA 1995;274:554-8.